Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Is a |
Salicylic acid product |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent kératolytique |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Salicylic acid (substance) |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Is a |
Product containing salicylic acid (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent topique |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Is a |
Product containing lactic acid (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lactic acid |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Is a |
Product containing lactic acid and salicylic acid (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Has manufactured dose form |
Cutaneous gel |
true |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Is a |
Product containing salicylic acid in topical dosage form |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
This attribute specifies the numerator unit for the concentration strength of a product. |
mg |
true |
Inferred relationship |
Some |
2 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Some |
2 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
This attribute specifies the denominator unit for the concentration strength of a product. |
g |
true |
Inferred relationship |
Some |
2 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
This attribute specifies the numerator unit for the concentration strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
This attribute specifies the denominator unit for the concentration strength of a product. |
g |
true |
Inferred relationship |
Some |
1 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Has concentration strength numerator value |
120 |
false |
Inferred relationship |
Some |
2 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Salicylic acid (substance) |
false |
Inferred relationship |
Some |
2 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Lactic acid |
false |
Inferred relationship |
Some |
1 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Has concentration strength numerator value |
40 |
false |
Inferred relationship |
Some |
1 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Lactic acid |
false |
Inferred relationship |
Some |
1 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Salicylic acid (substance) |
false |
Inferred relationship |
Some |
2 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Is a |
Lactic acid and salicylic acid only product in cutaneous dose form |
true |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Plays role |
Antifungal therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Lactic acid |
true |
Inferred relationship |
Some |
2 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Lactic acid |
true |
Inferred relationship |
Some |
2 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Salicylic acid (substance) |
true |
Inferred relationship |
Some |
1 |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Salicylic acid (substance) |
true |
Inferred relationship |
Some |
1 |
|